Literature DB >> 24742712

Unraveling structural mechanisms of allosteric drug action.

Ruth Nussinov1, Chung-Jung Tsai2.   

Abstract

Orthosteric drugs block the active site to obstruct function; allosteric drugs modify the population of the active state, to modulate function. Available data lead us to propose that allosteric drugs can constitute anchors and drivers. The anchor docks into an allosteric pocket. The conformation with which it interacts is unchanged during the transition between the inactive and active states. The anchor provides the foundation that allows the driver to exert a 'pull' and/or 'push' action that shifts the receptor population from the inactive to the active state. The presence or absence of driver atom in an allosteric drug can exert opposite agonism. We map a strategy for driver identification and expect the allosteric trigger concept to transform agonist/antagonist drug discovery.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Keywords:  agonist; allosteric drug discovery; allostery; anchor atom; antagonist; driver atom; protocol

Mesh:

Substances:

Year:  2014        PMID: 24742712     DOI: 10.1016/j.tips.2014.03.006

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  42 in total

1.  Parallel Allostery by cAMP and PDE Coordinates Activation and Termination Phases in cAMP Signaling.

Authors:  Srinath Krishnamurthy; Nikhil Kumar Tulsian; Arun Chandramohan; Ganesh S Anand
Journal:  Biophys J       Date:  2015-08-11       Impact factor: 4.033

2.  Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.

Authors:  Qian Wang; Maria V Liberti; Pei Liu; Xiaobing Deng; Ying Liu; Jason W Locasale; Luhua Lai
Journal:  Cell Chem Biol       Date:  2016-12-29       Impact factor: 8.116

3.  Hidden electrostatic basis of dynamic allostery in a PDZ domain.

Authors:  Amit Kumawat; Suman Chakrabarty
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-20       Impact factor: 11.205

Review 4.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

Authors:  Michelle R Arkin; Yinyan Tang; James A Wells
Journal:  Chem Biol       Date:  2014-09-18

5.  Heavy lessons in protein allostery.

Authors:  Lars Konermann
Journal:  Nat Struct Mol Biol       Date:  2016-06-07       Impact factor: 15.369

Review 6.  Engineered control of enzyme structural dynamics and function.

Authors:  David D Boehr; Rebecca N D'Amico; Kathleen F O'Rourke
Journal:  Protein Sci       Date:  2018-02-16       Impact factor: 6.725

7.  Noncognate DNA damage prevents the formation of the active conformation of the Y-family DNA polymerases DinB and DNA polymerase κ.

Authors:  Philip Nevin; Xueguang Lu; Ke Zhang; John R Engen; Penny J Beuning
Journal:  FEBS J       Date:  2015-05-11       Impact factor: 5.542

8.  Role of Dynamics in the Autoinhibition and Activation of the Hyperpolarization-activated Cyclic Nucleotide-modulated (HCN) Ion Channels.

Authors:  Bryan VanSchouwen; Madoka Akimoto; Maryam Sayadi; Federico Fogolari; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

9.  Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).

Authors:  Bryan VanSchouwen; Rajeevan Selvaratnam; Rajanish Giri; Robin Lorenz; Friedrich W Herberg; Choel Kim; Giuseppe Melacini
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

10.  Phosphorylated Calmodulin Promotes PI3K Activation by Binding to the SH2 Domains.

Authors:  Mingzhen Zhang; Hyunbum Jang; Vadim Gaponenko; Ruth Nussinov
Journal:  Biophys J       Date:  2017-11-07       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.